Anti-VEGF Use in Ophthalmology: A Comprehensive Guide

Anti-VEGF Use in Ophthalmology is a comprehensive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-vascular endothelial growth factor (VEGF) agents in the treatment of various ocular diseases. This book is a must-have for eye care professionals, including optometrists, residents, comprehensive ophthalmologists, and specialists in anterior segment, pediatrics, and vitreoretinal disease.

History of VEGF and Overview of Anti-VEGF Agents

The introduction of anti-VEGF agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. It is essential for eye care providers to be familiar with up-to-date aspects of the medications and indications for use.

Clinical Uses of Anti-VEGF Agents

The book is divided into two sections, with the second section detailing the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents.

Neovascular Age-Related Macular Degeneration

Neovascular age-related macular degeneration is a leading cause of vision loss in older adults. Anti-VEGF agents have been shown to significantly improve visual acuity and reduce the risk of vision loss in patients with this condition.

Proliferative Diabetic Retinopathy

Proliferative diabetic retinopathy is a complication of diabetes that can cause severe vision loss if left untreated. Anti-VEGF agents can help reduce the risk of vision loss by inhibiting the growth of new blood vessels that can cause retinal damage.

Retinal Vein Occlusion

Retinal vein occlusion is a condition in which the small veins in the retina become blocked, leading to vision loss. Anti-VEGF agents can help improve vision and reduce the risk of complications in patients with retinal vein occlusion.

Uveitis

Uveitis is a group of inflammatory eye conditions that can cause vision loss if left untreated. Anti-VEGF agents can help reduce inflammation and improve vision in patients with uveitis.

Neovascular Glaucoma

Neovascular glaucoma is a type of glaucoma that is caused by the growth of new blood vessels in the eye. Anti-VEGF agents can help reduce the risk of vision loss by inhibiting the growth of these new blood vessels.

Macular Edema

Macular edema is a condition in which fluid accumulates in the macula, the part of the retina responsible for central vision. Anti-VEGF agents can help reduce macular edema and improve vision in patients with this condition.

Retinopathy of Prematurity

Retinopathy of prematurity is a condition that affects premature infants and can cause vision loss if left untreated. Anti-VEGF agents can help reduce the risk of vision loss in these patients.

Corneal Disease

Corneal disease can cause vision loss if left untreated. Anti-VEGF agents can help improve vision and reduce the risk of complications in patients with corneal disease.

Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals. This comprehensive guide is essential for anyone looking to improve their understanding of anti-VEGF agents and their role in treating various ocular diseases.